Similarly, serum exosome CD44 concentration was positively correlated with lymph node tumor load and could be used as a potential therapeutic target and non-invasive biomarker for lymph node metastasis in gastric cancer [15]. This evidence concerns the gene CD44 and metastatic malignant neoplasm in the lymph nodes.